Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 360 participants.
Also called NCT06784466
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 360 participants
- Sponsor
- Arga Medtech SA
- Registry
-
NCT06784466
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Belgium, Croatia, Czechia, Lithuania, Netherlands
- Registry status
- Recruiting
Technical summary
Registry record NCT06784466. Non-randomized; no masking; primary purpose treatment. Start 2025-09-10 (actual); primary completion 2027-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
- Acronym
- COHERENT-AF
- Condition
- Atrial Fibrillation (AF)
- Condition
- Persistant Atrial Fibrillation
- Condition
- Paroxysmal AF
- Intervention (Device)
- Argá Medtech Coherent Sine-Burst Electroporation (CSE) Ablation System
- Lead sponsor
- Arga Medtech SA
Record details
- Record id
cardio:ct-nct06784466- Content hash
b9cd2c32c58bd6b1f872b23b1cbb30f34877157d1ec7422f685d87b2dcbf7403